From: The role of the fat mass and obesity associated gene (FTO) in breast cancer risk
 | Additive effects | Dominance effects | ||||
---|---|---|---|---|---|---|
Nonepistatic | Model 1a | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 |
rs9939609 | 0.919 (0.56-1.50) | 0.935 (0.56-1.55) | 0.956 (0.57-1.61) | 0.780 (0.52-1.17) | 0.796 (0.52-1.20) | 0.778 (0.50-1.12) |
rs1477196 | 2.379** (1.46-3.87) | 2.436** (1.48-4.00) | 2.611** (1.56-4.37) | 0.820 (0.55-1.22) | 0.787 (0.52-1.17) | 0.727 (0.47-1.10) |
rs7206790 | 1.573 (0.97-2.54) | 1.599 (0.98-2.61) | 1.652 (0.98-2.78) | 1.131 (0.76-1.68) | 1.140 (0.76-1.70) | 1.155 (0.76-1.76) |
rs8047395 | 0.772 (0.45-1.30) | 0.811 (0.47-1.38) | 0.787 (0.45-1.37) | 1.017 (0.66-1.55) | 1.041 (0.67-1.60) | 1.073 (0.68-1.69) |
 | Additive effects | Dominance effects | ||||
Single SNP | Model 1 a | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 |
rs9939609 | 0.997 (0.79,1.25) | 0.975 (0.77,1.23) | 0.992 (0.78, 1.26) | 0.814 (0.59,1.13) | 0.831 (0.60,1.16) | 0.776 (0.55,1.09) |
rs1477196 | 1.390* (1.10,1.76) | 1.408* (1.11,1.79) | 1.447* (1.13,1.85) | 0.809 (0.58,1.13) | 0.781 (0.56,1.09) | 0.693* (0.49,0.98) |
rs7206790 | 1.066 (0.87,1.32) | 1.054 (0.85,1.31) | 1.022 (0.82,1.28) | 0.969 (0.71,1.32) | 0.980 (0.72,1.34) | 0.949 (0.69,1.31) |
rs8047395 | 1.052 (0.85,1.30) | 1.054 (0.85,1.31) | 1.075 (0.86,1.34) | 0.878 (0.65,1.19) | 0.876 (0.64,1.19) | 0.812 (0.59.1.12) |